Roles of p53 in extrinsic factor-induced liver carcinogenesis

Abstract

Liver cancer remains one of the most common human cancers with a high mortality rate. Therapies for hepatocellular carcinoma (HCC) remain ineffective, due to the heterogeneity of HCC with regard to both the etiology and mutation spectrum, as well as its chemotherapy resistant nature; thus surgical resection and liver transplantation remain the gold standard of patient care. The most common etiologies of HCC are extrinsic factors. Humans have multiple defense mechanisms against extrinsic factor-induced carcinogenesis, of which tumor suppressors play crucial roles in preventing normal cells from becoming cancerous. The tumor suppressor p53 is one of the most frequently mutated genes in liver cancer. p53 regulates expression of genes involved in cell cycle progression, cell death, and cellular metabolism to avert tumor development due to carcinogens. This review article mainly summarizes extrinsic factors that induce liver cancer and potentially have etiological association with p53, including aflatoxin B1, vinyl chloride, non-alcoholic fatty liver disease, iron overload, and infection of hepatitis viruses.

Keywords

Aflatoxin B1 / vinyl chloride / iron overload / viral infection / infection / non-alcoholic fatty liver disease

References

[1] Bray F,Masuyer E.Global estimates of cancer prevalence for 27 sites in the adult population in 2008..Int J Cancer2013;132:1133-45

[2] Ferlay J,Dikshit R,Mathers C,Parkin DM,Bray F.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012..Int J Cancer2015;136:E359-86

[3] Jemal A,Center MM,Ward E.Global cancer statistics..CA Cancer J Clin2011;61:69-90

[4] Dhanasekaran R,Cabrera R.Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics..Hepat Med2012;4:19-37

[5] Strohmeyer G,Stremmel W.Survival and causes of death in hemochromatosis. Observations in 163 patients..Ann N Y Acad Sci1988;526:245-57

[6] Elzouki AN.Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?.Eur J Gastroenterol Hepatol1996;8:989-94

[7] Fracanzani AL,Fraquelli M,Mattioli M,Fargion S.Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease..Hepatology2001;33:647-51

[8] Chuang SC,Boffetta P.Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection..Cancer Lett2009;286:9-14

[9] Magnussen A.Aflatoxins, hepatocellular carcinoma and public health..World J Gastroenterol2013;19:1508-12 PMCID:PMC3602466

[10] Guyton KZ.Prevention of liver cancer..Curr Oncol Rep2002;4:464-70

[11] Wertheim JA,Saab S,Busuttil RW.Major challenges limiting liver transplantation in the United States..Am J Transplant2011;11:1773-84 PMCID:PMC3166424

[12] Cillo U,Polacco M,Crivellari G.Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation..World J Gastroenterol2016;22:232-52 PMCID:PMC4698488

[13] Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (editors). SEER Cancer Statistics Review, 1975-2013. Bethesda, MD: National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975_2013/. [Based on November 2015 SEER data submission; posted to the SEER web site on April 2016; last accessed on May 26, 2017].

[14] Vousden KH.p53 and metabolism..Nat Rev Cancer2009;9:691-700

[15] Lane D.p53 Research: the past thirty years and the next thirty years..Cold Spring Harb Perspect Biol2010;2:a000893

[16] Cleary SP,Zhao X,Selitsky SR,Tan TX,Getz G,Parker JS,Powers S,Fischer S,Ghanekar A.Identification of driver genes in hepatocellular carcinoma by exome sequencing..Hepatology2013;58:1693-702 PMCID:PMC3830584

[17] Schulze K,Letouzé E,Calderaro J,Couchy G,Shinde J,Calatayud AL,Pelletier L,Laurent A,Mazzaferro V,Villanueva A,Bioulac-Sage P,Llovet JM.Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets..Nat Genet2015;47:505-11

[18] Parrales A.Targeting oncogenic mutant p53 for cancer therapy..Front Oncol2015;5:288 PMCID:PMC4685147

[19] Iakova P,Timchenko NA.Intracellular signaling and hepatocellular carcinoma..Semin Cancer Biol2011;21:28-34 PMCID:PMC3228644

[20] Ranjan A,Iwakuma T.Murine double minute 2, a potential p53-independent regulator of liver cancer metastasis..Hepatoma Res2016;2:114-21 PMCID:PMC5609474

[21] Chen L,Chen W,Chen F,Zeng WT,Huang XH.MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53..Biomed Pharmacother2016;84:1113-8

[22] Shank RC.Metabolic activation of mycotoxins by animals and humans: an overview..J Toxicol Environ Health1977;2:1229-44

[23] Hsieh DP.Bisfuranoid mycotoxins: their genotoxicity and carcinogenicity..Adv Exp Med Biol1991;283:525-32

[24] Liu Y,Marsh GM.Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis..Eur J Cancer2012;48:2125-36

[25] Gross-Steinmeyer K.Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1)..Toxicology2012;299:69-79

[26] Smela ME,Bailey EA.The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis..Carcinogenesis2001;22:535-45

[27] Bressac B,Wands J.Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa..Nature1991;350:429-31

[28] Aguilar F,Cerutti P.Aflatoxin B1 induces the transversion of G-->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes..Proc Natl Acad Sci U S A1993;90:8586-90 PMCID:PMC47402

[29] Ming L,Gail MH,Harris CC,Shao Y,Liu G,Sun Z.Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China..Hepatology2002;36:1214-20

[30] Puisieux A,Groopman J.Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens..Cancer Res1991;51:6185-9

[31] Hussain SP.p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer..Mutat Res1999;428:23-32

[32] Ricordy R,Cacci E.Impairment of cell cycle progression by aflatoxin B1 in human cell lines..Mutagenesis2002;17:241-9

[33] Kim J,Do KH,Moon Y.Interference with mutagenic aflatoxin B1-induced checkpoints through antagonistic action of ochratoxin A in intestinal cancer cells: a molecular explanation on potential risk of crosstalk between carcinogens..Oncotarget2016;7:39627-39

[34] Lee YI,Das GC,Park SM.Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma..Oncogene2000;19:3717-26

[35] Whittaker S,Zhu AX.The role of signaling pathways in the development and treatment of hepatocellular carcinoma..Oncogene2010;29:4989-5005

[36] Weng CJ,Tsai CM,Ueng KC,Yeh YH,Chen YC,Yang SF.Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma..Ann Surg Oncol2010;17:1808-15

[37] Yao N,Wang L,Wu W,Yan X,Chen J,Zhang H.Inhibition of autocrine IGF-II on effect of human HepG2 cell proliferation and angiogenesis factor expression..Tumour Biol2012;33:1767-76

[38] Mastrangelo G,Fadda E,Agnesi R,Marchì T,Pinzani M.Increased risk of hepatocellular carcinoma and liver cirrhosis in vinyl chloride workers: synergistic effect of occupational exposure with alcohol intake..Environ Health Perspect2004;112:1188-92 PMCID:PMC1247480

[39] Dogliotti E.Molecular mechanisms of carcinogenesis by vinyl chloride..Ann Ist Super Sanita2006;42:163-9

[40] Dragani TA.Occupational exposure to vinyl chloride and risk of hepatocellular carcinoma..Cancer Causes Control2008;19:1193-200

[41] Sherman M.Vinyl chloride and the liver..J Hepatol2009;51:1074-81

[42] el Ghissassi F,Bartsch H.Metabolic activation of vinyl chloride by rat liver microsomes: low-dose kinetics and involvement of cytochrome P450 2E1..Biochem Pharmacol1998;55:1445-52

[43] Hollstein M,Lehman T,Harris CC,Kusters I.p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers..Carcinogenesis1994;15:1-3

[44] Trivers GE,DeBenedetti VM,Marion MJ,Hoover ML,Tamburro CC.Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride..J Natl Cancer Inst1995;87:1400-7

[45] Barbin A,Boivin S,Belpoggi F,Montesano R.p53 gene mutation pattern in rat liver tumors induced by vinyl chloride..Cancer Res1997;57:1695-8

[46] Smith SJ,Whitley R,Partilo S,Brandt-Rauf PW.Molecular epidemiology of p53 protein mutations in workers exposed to vinyl chloride..Am J Epidemiol1998;147:302-8

[47] Calzadilla Bertot L.The natural course of non-alcoholic fatty liver disease..Int J Mol Sci2016;17:774 PMCID:PMC4881593

[48] Bedogni G,Tiribelli C.Epidemiology of fatty liver: an update..World J Gastroenterol2014;20:9050-4

[49] Baffy G.Hepatocellular carcinoma in non-alcoholic fatty liver disease: epidemiology, pathogenesis, and prevention..J Clin Transl Hepatol2013;1:131-7

[50] Ertle J,Sowa JP,Herzer K,Schlaak JF,Syn WK.Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis..Int J Cancer2011;128:2436-43

[51] Sanyal AJ,Lencioni R.The etiology of hepatocellular carcinoma and consequences for treatment..Oncologist2010;15 Suppl 4:14-22

[52] Michelotti GA,Diehl AM.NAFLD, NASH and liver cancer..Nat Rev Gastroenterol Hepatol2013;10:656-65

[53] Tomita K,Suzuki T,Yokoyama H,Nishiyama K,Irie R,Okada Y,Ebinuma H,Shimizu I,Hokari R,Hatsuse K,Kanai T,Hibi T.p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice..J Hepatol2012;57:837-43

[54] Castro RE,Afonso MB,Machado MV,Rodrigues CM.miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease..J Hepatol2013;58:119-25

[55] Tian XF,Zang HL.Activation of the miR-34a/SIRT1/p53 signaling pathway contributes to the progress of liver fibrosis via inducing apoptosis in hepatocytes but not in HSCs..PLoS One2016;11:e0158657

[56] Ferreira DM,Rodrigues PM,Pereira DM,Rodrigues CM.c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver..Mol Cell Biol2014;34:1100-20 PMCID:PMC3958031

[57] Yamakuchi M.MiR-34, SIRT1 and p53: the feedback loop..Cell Cycle2009;8:712-5

[58] Chang TC,Kent OA,Mullendore M,Feldmann G,Ferlito M,Arking DE,Maitra A.Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis..Mol Cell2007;26:745-52 PMCID:PMC1939978

[59] Chifman J,Torti SV.A systems biology approach to iron metabolism..Adv Exp Med Biol2014;844:201-25 PMCID:PMC4464783

[60] Siddique A.Review article: the iron overload syndromes..Aliment Pharmacol Ther2012;35:876-93

[61] Heeney MM.Iron clad: iron homeostasis and the diagnosis of hereditary iron overload..Hematology Am Soc Hematol Educ Program2014;2014:202-9

[62] Torti SV.Iron and cancer: more ore to be mined..Nat Rev Cancer2013;13:342-55 PMCID:PMC4036554

[63] Kew MC.Hepatocellular carcinoma in African Blacks: recent progress in etiology and pathogenesis..World J Hepatol2010;2:65-73 PMCID:PMC2999270

[64] Asare GA,Kew MC,Mossanda KS.Iron-free neoplastic nodules and hepatocellular carcinoma without cirrhosis in Wistar rats fed a diet high in iron..J Pathol2006;208:82-90

[65] Kang JO,Brothwell B.Toxicity associated with iron overload found in hemochromatosis: possible mechanism in a rat model..Clin Lab Sci1998;11:350-4

[66] Jungst C,Gehrke R,Nischalke HD,Schramel P,Sauerbruch T.Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma..Hepatology2004;39:1663-72

[67] Asare GA,Kew MC,Kahler-Venter CP.Hepatocellular carcinoma caused by iron overload: a possible mechanism of direct hepatocarcinogenicity..Toxicology2006;219:41-52

[68] Shen J,Chang Z,Wang S,Li D,Shang Y,Yu L,Ruan K,Huang Y,Xie D,Hu R.Iron metabolism regulates p53 signaling through direct heme-p53 interaction and modulation of p53 localization, stability, and function..Cell Rep2014;7:180-93 PMCID:PMC4219651

[69] Bloomer SA.Tumour promotion versus tumour suppression in chronic hepatic iron overload..Cell Biochem Funct2015;33:241-8

[70] Zhang F,Tsuji Y,Torti FM.Post-transcriptional modulation of iron homeostasis during p53-dependent growth arrest..J Biol Chem2008;283:33911-8

[71] Funauchi Y,Yi Lo PH,Daigo Y,Miyagi Y,Nakamura Y.Regulation of iron homeostasis by the p53-ISCU pathway..Sci Rep2015;5:16497 PMCID:PMC4642350

[72] Vautier G,Portmann BC,Williams R.p53 mutations in british patients with hepatocellular carcinoma: clustering in genetic hemochromatosis..Gastroenterology1999;117:154-60

[73] Marrogi AJ,van Gijssel HE,Rahim H,Kowdley KV,Nair J,Okby N,Ishak KG.Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinoma..J Natl Cancer Inst2001;93:1652-5

[74] Ott JJ,Groeger J.Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity..Vaccine2012;30:2212-9

[75] Chan SL,Qin S.Infection and cancer: the case of hepatitis B..J Clin Oncol2016;34:83-90

[76] Tarocchi M,Marroncini G.Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis..World J Gastroenterol2014;20:11630-40 PMCID:PMC4155355

[77] El-Serag HB.Hepatocellular carcinoma: epidemiology and molecular carcinogenesis..Gastroenterology2007;132:2557-76

[78] Kew MC.Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma..J Gastroenterol Hepatol2011;26:144-52

[79] Datta S,Veer V.Molecular biology of the hepatitis B virus for clinicians..J Clin Exp Hepatol2012;2:353-65 PMCID:PMC3940099

[80] Seeger C.Molecular biology of hepatitis B virus infection..Virology2015;479–480:672-86

[81] Kim CM,Saito I,Jay G.HBx gene of hepatitis B virus induces liver cancer in transgenic mice..Nature1991;351:317-20

[82] Ueda H,Gangemi JD,Ngo L,Jay G.Functional inactivation but not structural mutation of p53 causes liver cancer..Nat Genet1995;9:41-7

[83] Wang XW,Yeh H,Gu JR.Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3..Proc Natl Acad Sci U S A1994;91:2230-4 PMCID:PMC43344

[84] Truant R,Greenblatt J,Cromlish JA.Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation..J Virol1995;69:1851-9

[85] Elmore LW,Chang SF,Chang S,Geller DA,Harris CC.Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis..Proc Natl Acad Sci U S A1997;94:14707-12 PMCID:PMC25100

[86] Kuo TC.Hepatitis B virus X protein prevents apoptosis of hepatocellular carcinoma cells by upregulating SATB1 and HURP expression..Biochem Pharmacol2010;80:1093-102

[87] Shih WL,Chuang SE,Doong SL.Hepatitis B virus X protein inhibits transforming growth factor-beta -induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway..J Biol Chem2000;275:25858-64

[88] Kim H,Yun Y.X-gene product of hepatitis B virus induces apoptosis in liver cells..J Biol Chem1998;273:381-5

[89] Terradillos O,Lecoeur H,Gougeon ML,Buendia MA.p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro..Oncogene1998;17:2115-23

[90] Schuster R,Schaefer S.Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts..Oncogene2000;19:1173-80

[91] Wang Y,Sham JS,Wang T.Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis..Oncogene2004;23:142-8

[92] Ma NF,Hu L,Wu J,Wang Y,Fung J,Tzang CH,Yang M,Guan XY.COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis..Clin Cancer Res2008;14:5061-8

[93] Liu LP,Ye C,Chen GG.HBx mutants differentially affect the activation of hypoxia-inducible factor-1alpha in hepatocellular carcinoma..Br J Cancer2014;110:1066-73 PMCID:PMC3929872

[94] Tu H,Giannini C,Soussan P,Paterlini-Bréchot P,Kremsdorf D.Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues..Cancer Res2001;61:7803-10

[95] Sirma H,Poussin K,Kremsdorf D.Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx..Oncogene1999;18:4848-59

[96] Zhang H,Li N,Zhang XZ,Zhang S,Ye LH.Identification of a natural mutant of HBV X protein truncated 27 amino acids at the COOH terminal and its effect on liver cell proliferation..Acta Pharmacol Sin2008;29:473-80

[97] Qian Y,Ma A,Xu G,Jing T,Liu Y,Liu Y.USP16 downregulation by carboxyl-terminal truncated HBx promotes the growth of hepatocellular carcinoma cells..Sci Rep2016;6:33039 PMCID:PMC5025738

[98] Huo TI,Forgues M,Spillare EA,Brechot C.Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis..Oncogene2001;20:3620-8

[99] Iyer S.Interaction of mutant hepatitis B X protein with p53 tumor suppressor protein affects both transcription and cell survival..Mol Carcinog2011;50:972-80 PMCID:PMC3125428

[100] Zhu R,Kang W,Yip WK,Lai PB,To KF,Cheng AS.Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis..J Pathol2015;237:38-49

[101] Long J,Li M,Jia JD.Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection..Oncol Rep2013;30:119-24

[102] Saitta C,Bertuccio A,Navarra G,Pollicino T.Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection..Cancer Genet2015;208:513-6

[103] Amaddeo G,Ladeiro Y,Nault JC,Gaston Mathe Y,Laurent A,Calderaro J.Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas..Gut2015;64:820-9 PMCID:PMC4392232

[104] Liu J,Zhang M,Zhang D,Wang F.Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis..Eur J Cancer2012;48:2328-38 PMCID:PMC3395767

[105] El-Serag HB.Epidemiology of viral hepatitis and hepatocellular carcinoma..Gastroenterology2012;142:1264-73.e1

[106] Mohd Hanafiah K,Flaxman AD.Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence..Hepatology2013;57:1333-42

[107] Choo QL,Han JH,Lee C,Gallegos C,Medina-Selby R.Genetic organization and diversity of the hepatitis C virus..Proc Natl Acad Sci U S A1991;88:2451-5 PMCID:PMC51250

[108] Clarke B.Molecular virology of hepatitis C virus..J Gen Virol1997;78:2397-410

[109] Bukh J.The history of hepatitis C virus (HCV): basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control..J Hepatol2016;65:S2-21

[110] Niederau C,Heintges T,Buschkamp M,Nawrocki M,Hensel F,Häussinger D.Prognosis of chronic hepatitis C: results of a large, prospective cohort study..Hepatology1998;28:1687-95

[111] Grebely J,Sacks-Davis R,Rice TM,Morris MD,Amin J,Kim AY,Schinkel J,Shoukry NH,Maher L,Hellard M,Prins M.The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection..Hepatology2014;59:109-20 PMCID:PMC3972017

[112] Bartosch B,Blum HE.Hepatitis C virus-induced hepatocarcinogenesis..J Hepatol2009;51:810-20

[113] Moriya K,Shintani Y,Tsutsumi T,Matsuura Y,Miyamura T.The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice..Nat Med1998;4:1065-7

[114] Lemon SM,Weinman SA.A transgenic mouse model of steatosis and hepatocellular carcinoma associated with chronic hepatitis C virus infection in humans..Trans Am Clin Climatol Assoc2000;111:146-56; discussion 156-7

[115] Ivanov AV,Petrushanko IY,Karpenko IL,Sominskaya I,Bartosch B,Isaguliants MG.HCV core protein uses multiple mechanisms to induce oxidative stress in human hepatoma Huh7 cells..Viruses2015;7:2745-70 PMCID:PMC4488712

[116] Marusawa H,Chiba T.Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation..J Virol1999;73:4713-20

[117] Liu J,Tang J,Shan X,Chen Q,Chen K,Tang N.Hepatitis C virus core protein activates Wnt/beta-catenin signaling through multiple regulation of upstream molecules in the SMMC-7721 cell line..Arch Virol2011;156:1013-23

[118] Kao CF,Chen JY.Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein..Oncogene2004;23:2472-83

[119] Feng S,Zhang J,Wang Q,Zhang M.Regulation of HepG2 cell apoptosis by hepatitis C virus (HCV) core protein via the sirt1-p53-bax pathway..Virus Genes2015;51:338-46

[120] He QQ,Sun Y,Chen ZC.Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 c-terminal deleted protein..World J Gastroenterol2003;9:474-8 PMCID:PMC4621564

[121] Lu L,Peng G,Wu K,Yan X,Wu J.NS3 protein of hepatitis C virus regulates cyclooxygenase-2 expression through multiple signaling pathways..Virology2008;371:61-70

[122] Feng DY,Cheng RX,Zheng H.Effect of hepatitis C virus nonstructural protein NS3 on proliferation and MAPK phosphorylation of normal hepatocyte line..World J Gastroenterol2005;11:2157-61 PMCID:PMC4305787

[123] Ishido S.Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor..FEBS Lett1998;438:258-62

[124] Kwun HJ,Ahn JY,Jang KL.p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3..J Gen Virol2001;82:2235-41

[125] Deng L,Tanaka M,Ikeda M,Sada K.NS3 protein of hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner..J Gen Virol2006;87:1703-13

[126] Sakamuro D,Takegami T.Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells..J Virol1995;69:3893-6

[127] Wang AG,Moon HB,Cho KH,Ha HL,Kim DG,Yu DY.Non-structural 5A protein of hepatitis C virus induces a range of liver pathology in transgenic mice..J Pathol2009;219:253-62

[128] Ghosh AK,Steele R,Ray R.Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death..Virus Res2000;67:173-8

[129] Yeh CT,Shyu WC,Yang PY,Lai HY.Characterization of a HCV NS5A protein derived from a patient with hepatoma..Biochem Biophys Res Commun2005;327:516-22

[130] Chung YL,Yen SH.Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma..Int J Cancer2003;107:65-73

[131] Majumder M,Steele R,Ray RB.Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner..J Virol2001;75:1401-7

[132] Lan KH,Hwang SJ,Chen SY,Wang YJ,Omata M,Lee SD.HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis..Oncogene2002;21:4801-11